(Q43033528)

12 November 2017

title

Chronic hepatitis C virus infection in renal transplant: treatment and outcome (English)

1 reference

12 November 2017

1 reference

1 reference

Sharma RK

1

1 reference

12 November 2017

Bansal SB

2

1 reference

12 November 2017

Gupta A

3

1 reference

12 November 2017

Gulati S

4

1 reference

12 November 2017

Kumar A

5

1 reference

12 November 2017

Prasad N

6

1 reference

12 November 2017

publication date

1 November 2006

1 reference

12 November 2017

published in

Clinical Transplantation

1 reference

12 November 2017

volume

20

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

677-683

1 reference

Hepatitis C virus and organ transplantation

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Liver disease after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Impact of hepatitis B and C virus on kidney transplantation outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Hepatitis C virus infection in kidney transplantation and a pilot study of the effects of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Treatment of hepatitis C virus infection with ribavirin in kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

The tolerance and efficacy of interferon‐α in haemodialysis patients with HCV infection: a multicentre, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00534.X

10.1111/J.1399-0012.2006.00534.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference